BackGreenLight Biosciences Overview

GreenLight Biosciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GRNA.

Quarterly EBIT

-$28.29M
↑ 23.08% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$155.43M
↓ 438.17% YoY

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin